Document is current
Any future updates will be listed below
-
Authors
Mor, Eyal https://orcid.org/0000-0002-3235-2946
Apte, Sameer
Bressel, Mathias
Broman, Kristy K
Hieken, Tina J.
Olofsson Bagge, Roger
Berman, Russell S.
Lee, Ann Y.
Kuijpers, Anke M.
Ollila, David W.
van Akkooi, Alexander C. J.
Zager, Jonathan S.
Gyorki, David E
- License Information
-
More Information
Article History
First Online: 16 March 2026
Disclosure
: Kristy Broman received grants for research outside this work from the NIH (NCATS, NCI), ASCO Conquer Cancer, and American College of Surgeons. Tina Hieken received research funding (institutional) from Genentech, SkylineDx. Roger Olofsson Bagge received institutional research grants from Bristol-Myers Squibb (BMS), Delcath Systems Inc., Endomagnetics Ltd (Endomag), SkyLineDx, and NeraCare GmbH and speaker honoraria from Bristol-Myers Squibb (BMS), Merck Sharp & Dohme (MSD), Roche, Pfizer and Pierre-Fabre, has served on advisory boards for Amgen, BD/BARD, Bristol-Myers Squibb (BMS), Merck Sharp & Dohme (MSD), Novartis, Roche and Sanofi Genzyme, and is a shareholder in SATMEG Ventures AB. Alexander Christopher Jonathan van Akkooi received honoraria and served in a consultancy or advisory role for Adium, Amgen, Bristol-Myers Squibb, Daiichi Sankyo, Genmab, Menarini Silicon Biosystems, Merck Serono-Pfizer, MSD Merck, Neracare, Novartis, Pierre Fabre, Provectus, Replimune, Sanofi, Sirius Medical, SkylineDx, 4SC, and received research funding from Amgen, Merck Serono–Pfizer, and SkylineDx.<PUB1>
